BioSurgery Market

Global Biosurgery Market Size (2023 to 2028)

The size of the global biosurgery market is forecasted to be worth USD 42.87 billion by 2028 and USD 27.9 billion in 2023, growing at a CAGR of 8.97% during the forecast period.

The biosurgery market is one of the fast-moving markets in the field of medicine. The biosurgery market relates to biological surgical sealing elements, bone graft substitutes and soft tissue management, hemostasis procedures, and traumatic injuries. The products offered by the biosurgery market help physicians and medical professionals alleviate trauma in patients efficiently and effectively. The pharmaceutical industry's growth has brought about an unprecedented increase in the demand for BioSurgery products. Biosurgery products' applications vary, using them in surgeries to minimize intraoperative and postoperative complications. Biosurgery has created a new potential in treatments like orthopedic, gynecology, neurosurgery, cardiovascular, and spine-related procedures with the right mix of biologics and synthetics. As a result of various researchers of biosurgery, it has given more and exciting prospects in this market.

Everyday biosurgery products include biological and chemical products used to stop bleeding and seal wounds in surgery. Other applications include facilitating hard tissue regeneration in orthobiologics and soft tissue repair in several surgical procedures. These advanced applications help enhance the work efficiency of physicians by controlling surgery-related difficulties with inexpensive and complicated surgeries. Some healthcare professionals focus more on introducing new prospects by developing novel biomaterials. For example, adhesion barriers, biological mesh, soft tissue attachment, collagen sealant, and fibrin are some biosurgery products for preventing excessive blood loss, wound healing, tissue sealing, and repairing bones or tissues that were damaged or weakened. The biosurgery mentioned above products were famous worldwide for improving physicians' work efficiency in complicated surgeries.

MARKET DRIVERS:

The global biosurgery market is expected to grow exponentially due to factors such as high investments in medicine, increased R&D investments, and technological advancements in surgery and patient care.

The significant factors affecting the bioSurgery market include the high investment, the increasing emphasis on R&D in the sector, the aggressive market strategies adopted by the top market players, technological advancements in the development of high-efficiency products, multi-usage products, and plasma-based products, and rising number of surgeries due to changing lifestyles and consumer awareness. Furthermore, an increase in the volume of surgeries and the prevalence of severe trauma injuries boost the market growth. In the present generation, lifestyle and eating habits have changed drastically, which leads to a significant increase in obesity and other lifestyle disorders, which is estimated to increase the number of surgeries around the globe and is predicted to drive the biosurgery market. These biosurgery products will be crucial in controlling blood loss and wound healing during different operations.

Additionally, the biosurgery market is driven by the introduction of advanced technologies, high investments, and new product launches by some top companies operating in the market. As the population in some countries rapidly increases, the need for surgeries also increases, which is estimated to favor the biosurgery market.

MARKET RESTRAINTS:

High costs associated with the advanced technologies used in biosurgeries are significant factors expected to restrain the global biosurgery market growth during the forecast period. Another challenge of the biosurgery market is the stringent regulatory approval process for biosurgery products. The governments of different countries are setting various regulations for using these biosurgery products. It is also one of the most significant restraints faced by many manufacturing companies of biosurgery products worldwide.

Impact of COVID-19 on the global biosurgery market:

The covid-19 pandemic has affected the global biosurgery market in both ways, due to the pandemic in-hospitalization treatment cases were reduced impacting the surgeries. There is a destabilization of supply and value chains, and they have negatively impacted the market in the short run. But, during the pandemic, there is a huge hospitalization rate of patients with comorbidities; they required many surgical procedures such as cardiovascular therapies, bleeding suppressants, and other trauma-related product usage. Even though COVID-19 has negatively impacted the market growth, it is for a short while, but in the aftermath of that, there is growth in healthcare, which has driven the market to travel on the growth line.

REPORT COVERAGE:

This research report on the global biosurgery market has been segmented and sub-segmented based on the type, application, and region.             

BioSurgery Market – By Type:

• Sealants
• Hemostatic Agents
• Adhesion Barriers
• Soft Tissue Attachments
• Bone Graft Substitutes
• Staple Line Reinforcement Agents

Based on type, the adhesion barriers and sealant segments are expected to grow at a high CAGR during the forecast period.

Surgical sealing agents are expected to do well during the forecast period as they find many applications in surgical procedures and contribute a lot to market expansion. Naturally sourced or biologically produced products lead the market share; as the market involves surgical procedures, the products must be miscible with the patient’s body. Hence there is a need for naturally sourced products.

BioSurgery Market - By Application:

• Orthopedic
• General
• Neurological
• Cardiovascular
• Reconstructive
• Gynecological
• Urological
• Thoracic Surgeries

Based on the application, the largest share of this market is accounted for by orthopedic surgery during the forecast period. The number of orthopedic surgeries is increasing gradually worldwide, resulting in the highest market share.

The neurological segment is expected to be another lucrative segment during the forecast period. In addition, the biosurgery market finds a lot of application in neurological surgeries and is expected to perform well over the forecast period.

BioSurgery Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• The Middle East and Africa

Geographically, the biosurgery market in North America accounted for the largest share in 20222, which has better technology, and the number of hospitals available is also more. The number of surgeries performed by the doctors in those hospitals in this region gradually increased, which resulted in a high market share among other areas.

The biosurgery market in Europe is also expected to increase the CAGR and its share in biosurgery products by manufacturing more biosurgery products and adopting new technologies to conduct more surgeries.

The biosurgery market in the Asia-Pacific is expected to grow rapidly in the coming years, as evidenced by the high CAGR value for the region. Likewise, another promising area for the market in Latin America is expected to show high growth rates in the coming years.

The biosurgery market in Latin America is driven by the increased clearance of biosurgery products by regulatory authorities. This along with factors such as the rising number of surgeries, increasing geriatric populations, lifestyle changes, and rising need for effective blood loss management bolster the market growth in the region.

The biosurgery market in the Middle East & Africa is driven by the increase in the geriatric population and the changing lifestyles worldwide. The rise in the number of spinal and sports injuries is also driving forward the biosurgery market as consumers also become aware of the latest medical practices.

KEY MARKET PARTICIPANTS:

Some prominent companies leading the Global Biosurgery Market profiled in this report are Baxter International, C.R. Bard, Johnson & Johnson, Covidien PLC, Getinge Group, B. Braun Melsungen AG, Cryolife Inc., Stryker Corporation, Hemostasis LLC., and Sanofi Group.